| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 05/07/2009 | US20090118329 Novel Substituted 2-Amino-4-Phenyldihydroquinolines, Processes for their Preparation, Pharmaceutical Compositions and Methods for Their Use |
| 05/07/2009 | US20090118327 Substituted 1-amino-4-phenyl-dihydroisoquinolines, methods for the production thereof, use thereof as a medicament, and medicaments containing them |
| 05/07/2009 | US20090118318 Novel Diazaspiroalkanes and Their Use for Treatment of CCR8 Mediated Diseases |
| 05/07/2009 | US20090118302 Novel Benzopyran Derivatives Having Inhibitory Activities Against Liver Fibrosis and Cirrhosis and Their Pharmaceutical Uses |
| 05/07/2009 | US20090118298 Octahydropentalene compounds as chemokine receptor antagonists |
| 05/07/2009 | US20090118278 Compositions useful as inhibitors of gsk-3 |
| 05/07/2009 | US20090118266 Novel 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivatives and their medical use |
| 05/07/2009 | US20090118265 Novel 1,4-diaza-bicyclo[3.2.2]nonane derivatives and their medical use |
| 05/07/2009 | US20090118249 Dheas inhalation compositions |
| 05/07/2009 | US20090118234 Novel phosphonic acid compounds as inhibitors of serine proteases |
| 05/07/2009 | US20090118229 Carotenoid-containing compositions and methods |
| 05/07/2009 | US20090118182 Fibroblast Growth Factor-Like Polypeptides |
| 05/07/2009 | US20090118160 Heterocyclic compounds and methods of use |
| 05/07/2009 | US20090117197 Compositions and methods for ameliorating cachexia |
| 05/07/2009 | US20090117193 Compositions Comprising an Active Agent |
| 05/07/2009 | US20090117133 POLYMERIC IMMUNOGLOBULIN FUSION PROTEINS THAT TARGET LOW AFFINITY FCyRECEPTORS |
| 05/07/2009 | US20090117131 Pharmaceutical Composition for The Treatment or Prevention of Allergic Diseases, Use Thereof, and A Method for The Treatment or Prevention of Allergic Diseases |
| 05/07/2009 | US20090117037 Methods Of Treatment Using CTLA-4 Antibodies |
| 05/07/2009 | US20090114226 Methods and devices for use in performing pulmonary procedures |
| 05/07/2009 | DE102008003054A1 Verwendungen von 2-(Piperidinyl)methyl-2,3-dihydroimidazo(1,2-c)chinazolin-5(6H)-on zum Bereitstellen einer analgetischen Wirkung, antiallergischen Wirkung und Histamin-H1-Rezeptorantagonismuswirkung Uses of 2- (piperidinyl) methyl-2,3-dihydroimidazo (1,2-c) quinazolin-5 (6H) -one for providing an analgesic effect, anti-allergic action and Histamine H1 receptor antagonism effect |
| 05/07/2009 | DE102007052380A1 Osmolythaltige Zubereitungen zur Anwendung bei trockenen Schleimhäuten Osmolythaltige preparations for use in dry mucous membranes |
| 05/07/2009 | CA2704357A1 Improved nogo-a binding molecules and pharmaceutical use thereof |
| 05/07/2009 | CA2704248A1 Calcium-rich alkaline powder produced from processed mollusc shells |
| 05/07/2009 | CA2704199A1 Amine derivative compounds for treating ophthalmic diseases and disorders |
| 05/07/2009 | CA2695628A1 Novel 6-triazolopyridazinesulfanyl benzothiazole and benzimidazole derivatives, method for production thereof and application as medicaments and pharmaceutical compositions and novel use as met inhibitors |
| 05/06/2009 | EP2055705A1 Compound having cyclic group bound thereto through spiro binding and use thereof |
| 05/06/2009 | EP2055696A1 Acid addition salts of mandelic acid derivatives |
| 05/06/2009 | EP2055308A1 Pharmaceutical for promoting functional regeneration of damaged tissue |
| 05/06/2009 | EP2055303A2 8-chloro-6, 11-dihydro-11-(4-piperidylidene)-5H-benzo [5,6] cyclohepta [1,2-b] pyridine oral compositions |
| 05/06/2009 | EP2054084A1 Aerosol formulation for the inhalation of beta agonists |
| 05/06/2009 | EP2054080A2 Treatment and prevention of allergic airways diseases |
| 05/06/2009 | EP2054057A1 Combination andolast/glucocorticoids |
| 05/06/2009 | EP2053915A2 Methods for attenuating release of inflammatory mediators and peptides useful therein |
| 05/06/2009 | EP1781686B1 Vla-4 antagonists |
| 05/06/2009 | EP1562603B1 Novel medicaments for the treatment of chronic obstructive pulmonary diseases |
| 05/06/2009 | EP1478398B1 New medicinal compositions on the basis of anticholinergic agents and egfr kinase inhibitors |
| 05/06/2009 | EP1443961B1 Glycoprotein compositions |
| 05/06/2009 | EP1420759B1 Pharmaceutical compositions for the treatment of asthma |
| 05/06/2009 | EP1414525B1 2-(3,5-bis-trifluoromethyl-phenyl)-n-¬6-(1,1-dioxo-1.lambda.6-thiomorpholin-4-yl)-4-(2-methyl or 4-fluoro-2-methyl substituted)phenyl-pyridin-3-yl -n-methyl-isobutyramide |
| 05/06/2009 | EP1308440B1 Piperidine derivatives and drugs containing these derivatives as the active ingredient |
| 05/06/2009 | EP1165114B1 Use of a lectin or conjugates for modulation of c-fibre activity |
| 05/06/2009 | CN101426792A Pyrazolopyrimidines as therapeutic agents |
| 05/06/2009 | CN101426777A Phenoxypiperidines and analogs thereof useful as histamine h3 antagonists |
| 05/06/2009 | CN101426765A Crystalline forms of a dimethylphenyl compound |
| 05/06/2009 | CN101426764A Dialkylphenyl compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
| 05/06/2009 | CN101426520A Treatment of severe community-acquired pneumonia by administration of tissue factor pathway inhibitor (TFPI) |
| 05/06/2009 | CN101426501A The use of beta-aminoalcohols for the treatment of inflammatory disorders and pain |
| 05/06/2009 | CN101426483A Purine derivatives as A2A receptor agonists |
| 05/06/2009 | CN101426482A Purine derivatives for use as adenosin A2A receptor agonists |
| 05/06/2009 | CN101423551A Isolated nucleic acid molecules which encode t cell inducible factors, or interleukin-21, the proteins encoded; and uses thereof |
| 05/06/2009 | CN101423516A Preparation of pidotimod sodium and medicinal use thereof |
| 05/06/2009 | CN101423500A Substituted benzoxazoles and analogues as estrogenic agents |
| 05/06/2009 | CN101422596A Preserved snake gall orange peel oral liquid and quality control method thereof |
| 05/06/2009 | CN101422594A Traditional Chinese medicine composition and preparation method thereof |
| 05/06/2009 | CN101422584A Multifunctional health-care medicine bag and production method thereof |
| 05/06/2009 | CN101422582A Traditional Chinese medicine oral liquid for treating livestock and poultry respiratory infection |
| 05/06/2009 | CN101422575A Traditional Chinese medicine oral liquid for treating livestock and poultry respirator infection |
| 05/06/2009 | CN101422564A Traditional Chinese medicine preparation for treating rhinitis |
| 05/06/2009 | CN101422563A Traditional Chinese medicine composition for treating wean sphagitis and preparation method and quality control method thereof |
| 05/06/2009 | CN101422559A Powder for treating cough phlegm dyspnea |
| 05/06/2009 | CN101422558A Traditional Chinese medicine for treating globus hystericus |
| 05/06/2009 | CN101422550A Medicine for treating chronic nasosnusitis |
| 05/06/2009 | CN101422545A External spraying agent for treating rhinitis and preparation method thereof |
| 05/06/2009 | CN101422535A Medicine for treating chronic nasosinusitis and complicating disease thereof |
| 05/06/2009 | CN101422522A Preparation method of traditional Chinese medicine preparation |
| 05/06/2009 | CN101422520A Traditional Chinese medicine oral liquid for treating livestock and poultry respiratory tract infection |
| 05/06/2009 | CN101422518A Preparation method of loquat flower extract |
| 05/06/2009 | CN101422510A Traditional Chinese medicine decoction for treating wind-heat type common cold |
| 05/06/2009 | CN101422508A Traditional Chinese medicine oral liquid for treating poultry respiratory tract infection |
| 05/06/2009 | CN101422487A Bear gall soft capsules and preparation method thereof |
| 05/06/2009 | CN101422479A Compound injection medicine composite for treating pig, cattle respiratory disease |
| 05/06/2009 | CN101422467A Immunosuppressant containing Withanolide type compound |
| 05/06/2009 | CN101422464A Compound fubennikao injection |
| 05/06/2009 | CN101422457A Tiotropium bromide respirable dry powder composition |
| 05/06/2009 | CN101422456A Medicine combination drop-pills and preparation method and quality detection method thereof |
| 05/06/2009 | CN101422428A Injection containing sodium pidotimod |
| 05/06/2009 | CN100484934C Processes for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinase |
| 05/06/2009 | CN100484570C Gene vaccine against SARS virogene and its construction and use |
| 05/06/2009 | CN100484558C Ginseng freeze-drying powdery injection and its quality control method |
| 05/06/2009 | CN100484556C Medicament for treating tonsillitis, preparation process and using method thereof |
| 05/06/2009 | CN100484515C Guacetisal dry-mixing suspending agents and method of preparing the same |
| 05/05/2009 | US7528162 such as 3-(4-Chlorophenyl)-N'-((4-chlorophenyl)sulfonyl)-N-(piperidin-1-yl)-4-phenyl-4,5-dihydro-1H-pyrazole-1-carboxamidine, used as cannabinoid (CB1) receptor antagonists, for prophylaxis of psychological disorders |
| 05/05/2009 | US7528156 Such as N-[2-(3-{[1-(3,4-dichlorobenzylpiperidinyl]aminohydroxypropoxy)phenyl]acetamide; antiinflammatory agents, antiarthritic agents; chronic obstructive pulmonary disease, asthma, multiple sclerosis |
| 05/05/2009 | US7528152 synthetic analog of Hemiasterlin; anticarcinogenic agent; restenosis of blood vessels subject to traumas such as angioplasty and stenting; safe and effective, while retaining stability in biological media; exhibit low cytotoxicity to non-dividing normal cells |
| 05/05/2009 | US7528149 e.g. N-[1-(2-aminoethyl)-4-piperidinyl]-7-methyl-3-(8-quinolinylmethyl)-3H-imidazo[4,5-b]pyridin-2-amine tetrahydrochloride trihydrate; immunostimulant; lower respiratory tract illness during infancy and childhood, asthma, pneumonia |
| 05/05/2009 | US7528110 Anti-allergic complex molecules |
| 05/05/2009 | CA2590540C The use of neurotoxic component of a botulinum toxin for the treatment of excessive mucus secretion |
| 05/05/2009 | CA2448281C Optical resolution of (1-benzyl-4-methylpiperidin-3-yl)-methylamine and the use thereof for the preparation of pyrrolo 2,3-pyrimidine derivatives as protein kinases inhibitors |
| 05/05/2009 | CA2322953C Pyridine derivative and pharmaceutical containing the same |
| 05/05/2009 | CA2311450C Pharmaceutical aerosol compositions |
| 05/01/2009 | CA2606828A1 Methods of assessing and treating pulmonary disease |
| 04/30/2009 | WO2009055571A2 Methods of treating pulmonary disorders using liposomal vancomycin formulations |
| 04/30/2009 | WO2009055568A2 Liposomal vancomycin formulations |
| 04/30/2009 | WO2009055044A1 Enhancement of plant growth |
| 04/30/2009 | WO2009054785A1 1,2,4-triazole ether derivatives as modulators of mglur5 |
| 04/30/2009 | WO2009054454A1 Regulator for signaling of toll-like receptor, which comprises cathepsin inhibitor as active ingredient |
| 04/30/2009 | WO2009053748A2 Novel crystalline forms |
| 04/30/2009 | WO2009053442A1 Use of trkb antibodies for the treatment of respiratory disorders |
| 04/30/2009 | WO2009053424A1 Crystalline salt of montelukast |
| 04/30/2009 | WO2009053268A1 Novel phenyl-substituted piperazino-dihydrothienopyrimidines |